Modulating cardiac hypertrophy by manipulating myocardial lipid metabolism?
Frey
Norbert
N
Olson
Eric N
EN
D000222:Adaptation, Physiological; D000818:Animals; D006332:Cardiomegaly / Q000378:metabolism* / Q000517:prevention & control / Q000628:therapy*; D004041:Dietary Fats; D005227:Fatty Acids / Q000378:metabolism; D005947:Glucose / Q000378:metabolism; D006579:Heterozygote; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology; D006946:Hyperinsulinism / Q000235:genetics / Q000517:prevention & control; D007004:Hypoglycemic Agents / Q000494:pharmacology; D008024:Ligands; D050356:Lipid Metabolism; D051379:Mice; D018345:Mice, Knockout; D009206:Myocardium / Q000378:metabolism*; D009928:Organ Specificity; D010084:Oxidation-Reduction; D018160:Receptors, Cytoplasmic and Nuclear / Q000235:genetics / Q000378:metabolism; D015398:Signal Transduction / Q000502:physiology; D014157:Transcription Factors / Q000235:genetics / Q000378:metabolism; D014158:Transcription, Genetic / Q000502:physiology
D004041:Dietary Fats; D005227:Fatty Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007004:Hypoglycemic Agents; D008024:Ligands; D018160:Receptors, Cytoplasmic and Nuclear; D014157:Transcription Factors; D005947:Glucose